{"resourceType":"Observation","id":"mii-exa-molgen-therapeutische-implikation-fgfr2-fusion","meta":{"profile":["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/therapeutische-implikation","http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory","display":"Laboratory"}]}],"code":{"coding":[{"system":"http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs","code":"therapeutic-implication","display":"Therapeutische Implikation"}]},"subject":{"reference":"Patient/mii-exa-molgen-patient-fgfr2-fusion"},"performer":[{"reference":"Practitioner/mii-exa-molgen-practitioner-lab"}],"derivedFrom":[{"reference":"Observation/mii-exa-molgen-variante-fgfr2-fusion"}],"component":[{"code":{"coding":[{"system":"http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs","code":"conclusion-string"}]},"valueString":"Hochselektiver FGFR2-Inhibitor RLY-4008 bei Patienten mit Cholangiokarzinomen und anderen soliden Tumoren, mit oder ohne FGFR- gerichtete Vortherapie."},{"code":{"coding":[{"system":"http://loinc.org","code":"51963-7","display":"Medication assessed [ID]"}]},"valueCodeableConcept":{"coding":[{"system":"http://www.whocc.no/atc","version":"2022","code":"L01EN","display":"Fibroblasten-Wachstumsfaktor-Rezeptor (FGFR)-Tyrosinkinase-Inhibitoren"},{"system":"http://snomed.info/sct","code":"1162485005","display":"Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)"}]}},{"code":{"coding":[{"system":"http://loinc.org","code":"93044-6"}]},"valueCodeableConcept":{"text":"m1c"}},{"code":{"coding":[{"system":"http://loinc.org","code":"81259-4"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"109842005","display":"Intrahepatic bile duct carcinoma (disorder)"},{"system":"http://fhir.de/CodeSystem/bfarm/icd-10-gm","version":"2022","code":"C22.1","display":"Intrahepatisches Gallengangskarzinom"}]}}]}